Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations. – FRONTIERS IN IMMUNOLOGY

Ciano-Petersen, NL; Aliaga-Gaspar, P; Hurtado-Guerrero, I; Reyes, V; Rodriguez-Bada, JL; Rodriguez-Traver, E; Brichette-Mieg, I; Fernandez, LL; Serrano-Castro, P; Alonso, A; Oliver-Martos, B – 2023 – 10.3389/fimmu.2023.1242508